(Q38524098)

3 September 2017

Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease (English)

1 reference

3 September 2017

0 references

1 reference

metabolic bone disease

1 reference

Duarte MP

1

1 reference

3 September 2017

Farias ML

2

1 reference

3 September 2017

Coelho HS

3

1 reference

3 September 2017

Mendonça LM

4

1 reference

3 September 2017

Stabnov LM

5

1 reference

3 September 2017

do Carmo d Oliveira M

6

1 reference

3 September 2017

Lamy RA

7

1 reference

3 September 2017

Oliveira DS

8

1 reference

3 September 2017

1 September 2001

1 reference

Journal of Gastroenterology and Hepatology

3 September 2017

1 reference

3 September 2017

16

1 reference

3 September 2017

9

1 reference

3 September 2017

1022-1027

1 reference

Prevalence and prediction of osteopenia in chronic liver disease

3 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Ethanol reduces bone formation and may cause osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Abnormal vitamin D metabolism in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Abnormal vitamin D metabolism in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

25-Hydroxylation of vitamin D in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Osteodystrophy in patients with chronic hepatitis and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Osteoporosis and skeletal fractures in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

Absence of hyperparathyroidism in severe liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02561.X

10.1046/J.1440-1746.2001.02561.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference